In ischemic stroke, apoptosis persists for days to weeks after the onset of an ischemic event. Cysteine-ASPartic proteASEs (caspases) are key mediators of apoptosis and neurodegeneration in stroke. The impact of caspase activity is not restricted to neuronal death, as caspases can exacerbate inflammation and alter glial function. Thus, caspases are logical therapeutic targets for this disease, but they have never been clinically evaluated due to a paucity of ideal drug candidates. Recent developments in caspase inhibition and drug delivery offer novel neuroprotective strategies for stroke, which are deliberated in this review.
AkpanNSerrano-SaizEZachariaBEOttenMLDucruetAFSnipasSJ, and others. 2011. Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. J Neurosci31:8894–904.
2.
Al-JamalKTGherardiniLBardiGNunesAGuoCBussyC, and others. 2011. Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci U S A108:10952–7.
3.
American College of Emergency Physicians. 2002. Use of intravenous tPA for the management of acute stroke in the emergency department (Policy Resource and Education Paper, Vol. 2012). Irving (TX): American College of Emergency Physicians.
4.
BenchouaAGueganCCouriaudCHosseiniHSampaioNMorinD, and others. 2001. Specific caspase pathways are activated in the two stages of cerebral infarction. J Neurosci21:7127–34.
5.
BenkovaBLozanovVIvanovIPMitevV. 2009. Evaluation of recombinant caspase specificity by competitive substrates. Anal Biochem394:68–74.
6.
BoysenGMarottJLGronbaekMHassanpourHTruelsenT. 2009. Long-term survival after stroke: 30 years of follow-up in a cohort, the Copenhagen City Heart Study. Neuroepidemiology33:254–60.
7.
CarandangRSeshadriSBeiserAKelly-HayesMKaseCSKannelWB, and others. 2006. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA296:2939–46.
8.
Centers for Disease Control and Prevention. 2001. Prevalence of disabilities and associated health conditions among adults—United States, 1999. MMWR Morb Mortal Wkly Rep50:120–5.
9.
Centers for Disease Control and Prevention. 2009. Prevalence and most common causes of disability among adults—United States, 2005. MMWR Morb Mortal Wkly Rep58:421–6.
CraftSBakerLDMontineTJMinoshimaSWatsonGSClaxtonA, and others. 2012. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol69:29–38.
12.
del ZoppoGJ. 2006. Stroke and neurovascular protection. N Engl J Med354:553–5.
13.
DhamoonMSMoonYPPaikMCBoden-AlbalaBRundekTSaccoRL, and others. 2009. Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke40:2805–11.
14.
DhuriaSVHansonLRFreyWH2nd. 2010. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci99:1654–73.
15.
DuanSRWangJXWangJXuRZhaoJKWangDS. 2010. Ischemia induces endoplasmic reticulum stress and cell apoptosis in human brain. Neurosci Lett475:132–5.
16.
EndresMNamuraSShimizu-SasamataMWaeberCZhangLGomez-IslaT, and others. 1998. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab18:238–47.
17.
FerrerIPlanasAM. 2003. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neuropathol Exp Neurol62:329–39.
18.
FriedlanderRM. 2000. Role of caspase 1 in neurologic disease. Arch Neurol. 57:1273–6.
19.
FriedlanderRMGagliardiniVHaraHFinkKBLiWMacDonaldG, and others. 1997. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med185:933–40.
20.
GinsbergMD. 2008. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology55:363–89.
21.
GreenDR. 2011. Immunology: a heavyweight knocked out. Nature479:48–50.
22.
HaraHFinkKEndresMFriedlanderRMGagliardiniVYuanJ, and others. 1997. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J Cereb Blood Flow Metab17:370–5.
23.
HarrisonDCDavisRPBondBCCampbellCAJamesMFParsonsAA, and others. 2001. Caspase mRNA expression in a rat model of focal cerebral ischemia. Brain Res Mol Brain Res89:133–46.
24.
HuesmannGRClaytonDF. 2006. Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation. Neuron52:1061–72.
25.
KangSJWangSHaraHPetersonEPNamuraSAmin-HanjaniS, and others. 2000. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol. 149:613–22.
26.
KrajewskiSKrajewskaMEllerbyLMWelshKXieZDeverauxQL, and others. 1999. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci U S A96:5752–7.
27.
LeDAWuYHuangZMatsushitaKPlesnilaNAugustinackJC, and others. 2002. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci U S A99:15188–93.
28.
LiptonP. 1999. Ischemic cell death in brain neurons. Physiol Rev79:1431–568.
29.
LuthiAUMartinSJ. 2007. The CASBAH: a searchable database of caspase substrates. Cell Death Differ14:641–50.
30.
Martin-VillalbaAHahneMKleberSVogelJFalkWSchenkelJ, and others. 2001. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ8:679–86.
31.
McStayGPSalvesenGSGreenDR. 2008. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ15:322–31.
32.
NiizumaKEndoHNitoCMyerDJKimGSChanPH. 2008. The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats. Proc Natl Acad Sci U S A105:16368–73.
33.
NiizumaKYoshiokaHChenHKimGSJungJEKatsuM, and others. 2010. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta1802:92–99.
34.
O’BrienT (2007), “Caspase Inhibitors in Drug Discovery”, in HengartnerM (ed.), Apoptosis: Fundamentals, Pathways, Clinical Applications and Role in Disease, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (online at http://hstalks.com/bio).
35.
PopCSalvesenGS. 2009. Human caspases: activation, specificity, and regulation. J Biol Chem284:21777–81.
36.
RibeEMSerrano-SaizEAkpanNTroyCM. 2008. Mechanisms of neuronal death in disease: defining the models and the players. Biochem J415:165–82.
SchweizerABriandCGrutterMG. 2003. Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway. J Biol Chem278:42441–7.
39.
StrbianDMeretojaAPutaalaJKasteMTatlisumakT. 2012. Cerebral edema in acute ischemic stroke patients treated with intravenous thrombolysis. Int J Stroke. doi:10.1111/j.1747-4949.2012.00781.x
40.
StrohCSchulze-OsthoffK. 1998. Death by a thousand cuts: an ever increasing list of caspase substrates. Cell Death Differ5:997–1000.
41.
ThorneRGPronkGJPadmanabhanVFreyWH2nd. 2004. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience127: 481–96.
42.
VelierJJEllisonJAKiklyKKSperaPABaroneFCFeuersteinGZ. 1999. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J Neurosci19:5932–41.
43.
VeneroJLBurguillosMABrundinPJosephB. 2011. The executioners sing a new song: killer caspases activate microglia. Cell Death Differ18:1679–91.
44.
WangJWeiQWangCYHillWDHessDCDongZ. 2004. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem279:19948–54.
45.
WestphalDDewsonGCzabotarPEKluckRM. 2011. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta1813:521–31.
46.
YrjanheikkiJTikkaTKeinanenRGoldsteinsGChanPHKoistinahoJ. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A96:13496–500.
47.
YuanJ. 2009. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis14:469–77.
